MMP-1 (519 A/G) and TIMP-1 (372 T/C) genes polymorphism in an Egyptian sample of Acne vulgaris patients

Shimaa Moustafa Ali Mohammed1, Hanan Hassan Sabry2, Seham Gouda Ameen3

  • 1Dermatology Resident in Kafr Shokr Hospital, Qalubia, Egypt.

Abstract

Insights

Gene variations in MMP-1 and TIMP-1 are linked to acne vulgaris development. Specific genotypes of MMP-1 (519 A/G) and TIMP-1 (372 T/C) increase acne risk, particularly in females.

Area of Science:

  • Genetics
  • Dermatology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are implicated in acne vulgaris pathogenesis.
  • The specific roles of MMP-1 and TIMP-1 gene polymorphisms in acne development remain under-researched.

Purpose of the Study:

  • To investigate the association between MMP-1 (519 A/G) and TIMP-1 (372 T/C) gene polymorphisms and the risk of acne vulgaris.
  • To analyze these genetic variations in Egyptian acne patients.

Main Methods:

  • A case-control study involving 100 acne vulgaris patients and 120 healthy controls.
  • Acne severity was assessed using the Global Acne Grading System (GAGS).
  • MMP-1 and TIMP-1 gene polymorphisms were identified using the RFLP-PCR technique.

Main Results:

  • MMP-1 (519 A/G) AG and GG genotypes, along with the G allele, were found to increase acne vulgaris risk by 2-3 fold.
  • In female patients, TIMP-1 (372 T/C) TT genotype and T allele were significantly more frequent, increasing acne risk (p < 0.01).
  • TIMP-1 (372 T/C) TT genotype in females correlated with family history, increased back acne, severe grades, and post-acne scarring.

Conclusions:

  • MMP-1 (519 A/G) and TIMP-1 (372 T/C) gene polymorphisms are potential risk factors for acne vulgaris development.
  • These genetic variations may influence acne severity and presentation, especially in females.